Tricyclic compounds useful as angiotensin ii agonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 233/54 (2006.01) A61K 31/4174 (2006.01) A61P 43/00 (2006.01) C07D 409/10 (2006.01) C07D 521/00 (2006.01) G01N 33/00 (2006.01)

Patent

CA 2449150

There is provided compounds of formula (I), wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4, Z1, Z2, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.

L'invention concerne des composés de formule (I), dans laquelle X¿1?, X¿2?, X¿3?, X¿4?, Y¿1?, Y¿2?, Y¿3?, Y¿4?, Z¿1?, Z¿2?, R?4¿ et R?5¿ ont les significations indiquées dans la description, ainsi que des sels pharmaceutiquement acceptables de ceux-ci. Ces composés sont utiles comme agonistes sélectifs du récepteur AT2 et donc, en particulier, pour traiter notamment des affections gastro-intestinales, telles que la dyspepsie, le syndrome du côlon irritable et le syndrome de défaillance polyviscérale, ainsi que des troubles cardiovasculaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tricyclic compounds useful as angiotensin ii agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic compounds useful as angiotensin ii agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds useful as angiotensin ii agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1415089

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.